Last reviewed · How we verify
Placebo to match zasocitinib — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo to match zasocitinib (Placebo to match zasocitinib) — Takeda. This drug is a placebo used to match the effects of zasocitinib.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo to match zasocitinib TARGET | Placebo to match zasocitinib | Takeda | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo to match zasocitinib CI watch — RSS
- Placebo to match zasocitinib CI watch — Atom
- Placebo to match zasocitinib CI watch — JSON
- Placebo to match zasocitinib alone — RSS
Cite this brief
Drug Landscape (2026). Placebo to match zasocitinib — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-to-match-zasocitinib. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab